Saudi Vigilance Program: Challenges and lessons learned
Pharmacovigilance is vital to public health. Adopting a robust spontaneous reporting system for adverse drug events can counteract most hazards that arise from utilizing medicinal products. Prior to the establishment of the Saudi Food and Drug Authority (SFDA), the number of pharmacovigilance-relate...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-03-01
|
| Series: | Saudi Pharmaceutical Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S131901641830001X |
| _version_ | 1811197686544596992 |
|---|---|
| author | Adel Alharf Nasser Alqahtani Ghazi Saeed Ali Alshahrani Mubarak Alshahrani Nasser Aljasser Mohammed Alquwaizani Saleh Bawazir |
| author_facet | Adel Alharf Nasser Alqahtani Ghazi Saeed Ali Alshahrani Mubarak Alshahrani Nasser Aljasser Mohammed Alquwaizani Saleh Bawazir |
| author_sort | Adel Alharf |
| collection | DOAJ |
| description | Pharmacovigilance is vital to public health. Adopting a robust spontaneous reporting system for adverse drug events can counteract most hazards that arise from utilizing medicinal products. Prior to the establishment of the Saudi Food and Drug Authority (SFDA), the number of pharmacovigilance-related activities in Saudi Arabia was limited. In 2009, the SFDA established the National Pharmacovigilance and Drug Safety Center (Saudi Vigilance). The pharmacovigilance system has remarkably improved during the past few years. Several initiatives have been taken to improve the program’s performance. These initiatives include initiation of pharmacovigilance guidelines, enhancement of communication and reporting tools, training sessions for concerned staff and healthcare providers, and compliance from stakeholders. This review article provides an overview of what the Saudi Vigilance program is, focusing on the scope, mission and vision, hierarchy, operational themes, and overall work processes. Additionally, we will shed light on the challenges we encountered during the early phase and on our future plans. |
| first_indexed | 2024-04-12T01:18:37Z |
| format | Article |
| id | doaj.art-4886723faf0640beaccb1fe913db6ffa |
| institution | Directory Open Access Journal |
| issn | 1319-0164 |
| language | English |
| last_indexed | 2024-04-12T01:18:37Z |
| publishDate | 2018-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Saudi Pharmaceutical Journal |
| spelling | doaj.art-4886723faf0640beaccb1fe913db6ffa2022-12-22T03:53:52ZengElsevierSaudi Pharmaceutical Journal1319-01642018-03-0126338839510.1016/j.jsps.2018.01.002Saudi Vigilance Program: Challenges and lessons learnedAdel Alharf0Nasser Alqahtani1Ghazi Saeed2Ali Alshahrani3Mubarak Alshahrani4Nasser Aljasser5Mohammed Alquwaizani6Saleh Bawazir7Saudi Food and Drug Authority, Saudi Arabia; Corresponding author.Saudi Food and Drug Authority, Saudi ArabiaSaudi Food and Drug Authority, Saudi ArabiaSaudi Food and Drug Authority, Saudi ArabiaSaudi Food and Drug Authority, Saudi ArabiaSaudi Food and Drug Authority, Saudi ArabiaSaudi Food and Drug Authority, Saudi ArabiaKing Saud University, Saudi ArabiaPharmacovigilance is vital to public health. Adopting a robust spontaneous reporting system for adverse drug events can counteract most hazards that arise from utilizing medicinal products. Prior to the establishment of the Saudi Food and Drug Authority (SFDA), the number of pharmacovigilance-related activities in Saudi Arabia was limited. In 2009, the SFDA established the National Pharmacovigilance and Drug Safety Center (Saudi Vigilance). The pharmacovigilance system has remarkably improved during the past few years. Several initiatives have been taken to improve the program’s performance. These initiatives include initiation of pharmacovigilance guidelines, enhancement of communication and reporting tools, training sessions for concerned staff and healthcare providers, and compliance from stakeholders. This review article provides an overview of what the Saudi Vigilance program is, focusing on the scope, mission and vision, hierarchy, operational themes, and overall work processes. Additionally, we will shed light on the challenges we encountered during the early phase and on our future plans.http://www.sciencedirect.com/science/article/pii/S131901641830001XPharmacovigilanceSaudi Vigilance ProgramSaudi Food and Drug Authority |
| spellingShingle | Adel Alharf Nasser Alqahtani Ghazi Saeed Ali Alshahrani Mubarak Alshahrani Nasser Aljasser Mohammed Alquwaizani Saleh Bawazir Saudi Vigilance Program: Challenges and lessons learned Saudi Pharmaceutical Journal Pharmacovigilance Saudi Vigilance Program Saudi Food and Drug Authority |
| title | Saudi Vigilance Program: Challenges and lessons learned |
| title_full | Saudi Vigilance Program: Challenges and lessons learned |
| title_fullStr | Saudi Vigilance Program: Challenges and lessons learned |
| title_full_unstemmed | Saudi Vigilance Program: Challenges and lessons learned |
| title_short | Saudi Vigilance Program: Challenges and lessons learned |
| title_sort | saudi vigilance program challenges and lessons learned |
| topic | Pharmacovigilance Saudi Vigilance Program Saudi Food and Drug Authority |
| url | http://www.sciencedirect.com/science/article/pii/S131901641830001X |
| work_keys_str_mv | AT adelalharf saudivigilanceprogramchallengesandlessonslearned AT nasseralqahtani saudivigilanceprogramchallengesandlessonslearned AT ghazisaeed saudivigilanceprogramchallengesandlessonslearned AT alialshahrani saudivigilanceprogramchallengesandlessonslearned AT mubarakalshahrani saudivigilanceprogramchallengesandlessonslearned AT nasseraljasser saudivigilanceprogramchallengesandlessonslearned AT mohammedalquwaizani saudivigilanceprogramchallengesandlessonslearned AT salehbawazir saudivigilanceprogramchallengesandlessonslearned |